Infective endocarditis complicating rituximab (anti-CD20 monoclonal antibody) treatment in an SLE patient with a past history of Libman–Sacks endocarditis: a case for antibiotic prophylaxis?

By Armstrong David   Wright Stephen   McVeigh Claire   Finch Michael  

Clinical Rheumatology, Vol. 25, Iss. 4, 2006-07 ,pp. : 583-584

Springer Publishing Company

Access to resources Recommend Favorite

Efalizumab, a Human Monoclonal Anti-CD11a Antibody, in the Treatment of Moderate to Severe Crohn’s Disease: An Open-Label Pilot Study

By James Dustin   Seo Da   Chen Jiajing   Vemulapalli Caroline   Stone Christian  

Digestive Diseases and Sciences, Vol. 56, Iss. 6, 2011-06 ,pp. : 1806-1810

Springer Publishing Company

Access to resources Recommend Favorite

Biopsy-verified response of severe lupus nephritis to treatment with rituximab (anti-CD20 monoclonal antibody) plus cyclophosphamide after biopsy-documented failure to respond to cyclophosphamide alone

By Vollenhoven RF van   Gunnarsson I   Welin-Henriksson E   Sundelin B   Österborg A   Jacobson SH   Klareskog L  

Scandinavian Journal of Rheumatology, Vol. 33, Iss. 6, 2004-11 ,pp. : 423-427

Informa Healthcare

Access to resources Recommend Favorite

PS-Liposome and Ox-LDL Bind to Different Sites of the Immunodominant Domain (#155-183) of CD36 - A Study with GS95, a New Anti-CD36 Monoclonal Antibody

By Yamaguchi A.   Yamamoto N.   Akamatsu N.   Saido T.C.   Kaneda M.   Umeda M.   Tanoue K.  

Thrombosis Research, Vol. 97, Iss. 5, 2000-03 ,pp. : 317-326

Elsevier

Access to resources Recommend Favorite

The importance of anti-insulin antibody in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion or multiple daily insulin injections therapy

By Sahin S.  

Acta Diabetologica, Vol. 47, Iss. 4, 2010-12 ,pp. : 325-330

Springer Publishing Company

Access to resources Recommend Favorite